Latest news with #MGI
Yahoo
15-07-2025
- Business
- Yahoo
Cities can fight back with guaranteed income programs
Mayors for a Guaranteed Income helped fund a pilot project at Santa Fe Community College. (Courtesy SFCC) If you are like me, you are still reeling from the news that the 'big beautiful bill' (which is unparalleled in its ugliness) received the necessary votes in the U.S. House and Senate, along with the president's signature. Although the U.S. Senate was close (and Dem senators all voted nay) what kind of madness is this? The very notion of passing legislation that dismantles Medicaid; blunts the effectiveness of nutritional assistance; and cuts funding to rural hospitals highlights the degree that a philosophy of philistine self-interest has infiltrated the current political climate. Trepidation over the fallout spreads nationwide. Gov. Michelle Lujan Grisham says the bill 'will hit New Mexico hard' and state officials have outlined nightmarish scenarios in which more than 88,000 New Mexicans lose Medicaid and more than 58,000 to lose their Supplemental Assistance Program help. 'This is draconian,' Victor Pineda, executive director of the Center for Independent Living in Berkeley, California, which provides quality of life assistance to the disabled, reportedly said. 'The cuts are a direct hit to our ability to help people stay in their homes who will now be forced into homelessness or institutions.' In the meantime, what can help supplement the loss of basic services in underserved communities? What can cities and mayors do? For one thing: They can put more of their remaining resources toward expanding guaranteed income programs. In 2018, Mayor Michael Tubbs of Stockton, Calif. initiated the first guaranteed income program in the USA, which for two years gave $500 every month to 125 low-income residents. A study in the program's aftermath conducted by a team of independent researchers determined that the money significantly improved participants' mental health and financial standing. Tubbs then founded Mayors for Guaranteed Income (MGI), a network of committed cities that have sponsored pilot programs in cities including Madison, Wis.; Pittsburgh, Pa; New Orleans, La.; and Santa Fe, here in New Mexico. In 2021, with an MGI grant, Santa Fe Mayor Alan Webber launched a pilot program that provided $400-per-month stipends to 100 young, low-income Santa Fe Community College students with child-caretaking responsibilities. A 2025 independent study again concluded that rather than fulfilling easy cliches — meaning the assumption the young grantees would waste the funds on alcohol or video games — participants experienced meaningful improvements in key takeaway areas 'This successful program directly addresses the fundamental problem that is holding New Mexico back: poverty.' said Mayor Webber, after the report was released. Today, more than 100 cities have sponsored direct cash payment programs that lasted one year (or preferably two years). In every case, most participants experienced admirable gains in food and housing security. In Santa Fe, participants experienced a 19 percentage point rise in full employment. But why should these results be surprising when 37% of Americans say they fear an unexpected $400 expense? A consistent extra few hundred (in lieu of having an empty bank account) can make a difference, a larger-than-expected step forward. For proponents, an important assurance is that guaranteed income programs come with 'no strings attached.' A family that needs money to pay for school supplies can choose this option; a recipient who knows that buying a car would be a valuable investment can save for that. Guaranteed income programs have been praised for having an 'entrepreneurial' spirit. But I believe the better word for them is 'self-empowering' in that they encourage the underprivileged to value themselves and invest in their own futures. These humble sums of cash directed without stipulations at crisis communities, including immigrant families, students or homeless youth, provide a measurable boost. Related programs stipulate the money is spent toward specific goals, like preventing homelessness. Funding for renters facing eviction is one of the most important ways cities, including Santa Fe, can potentially use targeted funds in a time when homelessness is at its highest level since the U.S. Department of Housing and Urban Development began keeping statistics in 2007. Here is the rub. These programs abet and enhance the social safety net. They cannot replace it. These programs are a tool: a necessary weapon. Times may become desperate. Cities must fight back.
Korea Herald
14-07-2025
- Science
- Korea Herald
MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
AUCKERLAND, New Zealand, July 14, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, is proud to announce that it has been awarded the Green World Champion in the Environmental Improvement: Conservation & Wildlife Projects sector of Green World Award 2025. This award recognizes MGI's groundbreaking efforts in utilizing genomics technology to support the conservation of Thai mangrove species. MGI's collaboration with the Thai National Omics Center aims to introduce genetic diversity into mangrove conservation strategies, significantly enhancing traditional biodiversity preservation methods. Mangroves have long been recognized for their critical ecological and economic roles in coastal regions. In Thailand, mangrove ecosystems serve essential functions by protecting shorelines and supporting the fishing industry. However, these ecosystems are increasingly threatened by environmental challenges that leave them vulnerable and at risk of disappearance, making conservation efforts more crucial than ever. Understanding the genetic diversity of mangroves is essential for developing effective conservation strategies. Genetic data reveals how species adapt to challenges such as rising sea levels, changes in salinity, and habitat loss. MGI's proprietary DNBSEQ™ technology plays a vital role in this effort. By supporting the mangrove research initiatives at the Thai National Omics Center, MGI empowers Thai researchers to delve deeply into the genetic complexities of mangroves with unprecedented precision. To date, MGI's DNBSEQ™ technology has facilitated the mapping of genetic diversity for 15 mangrove species in Thailand and establishment of a comprehensive reference genome database, providing invaluable insights for crafting effective conservation strategies. Established in 1994, the Green World Awards are among the most esteemed environmental awards globally. Organized by The Green Organisation, a non-profit, non-political environmental membership group, the awards celebrate and promote environmental best practices across diverse sectors, including commerce, industry, government, and individuals who make a positive impact on the environment. This year, MGI is one of only a select few out of more than 500 total entries to receive the Green World Champion award, highlighting the exceptional recognition that MGI's sequencing technology has garnered in the field of environmental conservation. Duncan Yu, the President of MGI, expressed his gratitude by stating, "We are honored to receive the Green World Champion award, which reflects our ongoing commitment to making a positive impact on society and the environment. At MGI, we are dedicated to using our advanced sequencing technology to support initiatives that protect our planet. By providing innovative genomic solutions, we aim to promote long-term sustainable development that benefits both the global community and ecosystems. Our work in mangrove conservation exemplifies our commitment to using science and technology to tackle pressing environmental challenges." About MGI: MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future.
Malaysian Reserve
11-06-2025
- Business
- Malaysian Reserve
MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia
SINGAPORE, June 11, 2025 /PRNewswire/ — MGI Tech Co., Ltd. ('MGI'), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Asia Pathogen Genomics Initiative ('Asia PGI'), part of the Duke-NUS Centre for Outbreak Preparedness (COP), have recently announced collaboration aimed at enhancing pathogen genomics sequencing efforts across Asia. This collaboration underscores a shared commitment to supporting public health initiatives through advanced life science technology. As part of this collaboration, MGI and Asia PGI will jointly democratize the pathogen genomics sequencing technology in Singapore and across Asia. The collaborative efforts will include hosting webinars to provide practical knowledge in pathogen genomics sequencing and delivering hands-on technical training to institutions and laboratories aimed at improving capacity development in pathogen detection. In addition, MGI also announced the launch of the MGI APAC Pandemic Preparedness Program (PPP) to strengthen the capabilities of genomics institutions and laboratories in pathogen surveillance. In collaboration with Asia PGI, the PPP aims to broaden the scope of pathogen surveillance solutions available to partner countries. The program offers a differentiated and sustainable alternative, focusing on application-centric and workflow-driven solutions. For example, it supports the development of equitable, effective, relevant, and validated workflow solutions to address acute infectious diseases. 'At the Duke-NUS Centre for Outbreak Preparedness, we believe that equitable access to pathogen genomic sequencing is fundamental to strengthening health security across South and Southeast Asia,' said Paul Pronyk, Director of COP. 'By collaborating with industry partners such as MGI, we are committed to ensuring that all communities in our region benefit from the latest advances in pathogen genomics – enabling early detection, informed response and ultimately, a healthier future for all.' 'We are proud to partner with Asia PGI to accelerate the application of cutting-edge sequencing technology in pathogen genomics,' said Roy Tan, General Manager of MGI Asia Pacific. 'Pathogen control is a pressing challenge for many countries in Asia. This partnership aims to improve the accessibility of pathogen genomics, empowering researchers and public health professionals in their fight against infectious diseases.' In response to the growing demand for rapid and precise detection of infectious diseases, MGI has developed a diverse array of comprehensive products for various applications, including metagenomic sequencing, targeted sequencing, and whole genome sequencing of pathogenic microorganisms. Looking ahead, MGI is committed to continuing its innovation, providing automated, convenient, and efficient core tools for pathogen identification, drug resistance analysis, and traceability. For more information of PPP, please visit: About the Duke-NUS Centre for Outbreak Preparedness (COP) and its Asia Pathogen Genomic Initiative (Asia PGI) The Duke-NUS Centre for Outbreak Preparedness (COP) was established in 2022 to address the growing need for enhanced preparedness and response to infectious disease outbreaks in the Asian region. With a mission to bridge the gap between research, training, policy and practice, COP aims to enhance regional health security across South and Southeast Asia. The Asia Pathogen Genomic Initiative (Asia PGI) is a flagship initiative of COP, aiming to harness scientific and technical partnerships across Singapore and Asia to advance genomic sequencing for infectious disease elimination. For more information, please visit About Duke-NUS Medical School Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has spawned 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives. For more information, please visit About MGI MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. For more information, please visit the MGI website or connect with us on Twitter, LinkedIn or YouTube.
Yahoo
11-06-2025
- Business
- Yahoo
MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia
SINGAPORE, June 11, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Asia Pathogen Genomics Initiative ("Asia PGI"), part of the Duke-NUS Centre for Outbreak Preparedness (COP), have recently announced collaboration aimed at enhancing pathogen genomics sequencing efforts across Asia. This collaboration underscores a shared commitment to supporting public health initiatives through advanced life science technology. As part of this collaboration, MGI and Asia PGI will jointly democratize the pathogen genomics sequencing technology in Singapore and across Asia. The collaborative efforts will include hosting webinars to provide practical knowledge in pathogen genomics sequencing and delivering hands-on technical training to institutions and laboratories aimed at improving capacity development in pathogen detection. In addition, MGI also announced the launch of the MGI APAC Pandemic Preparedness Program (PPP) to strengthen the capabilities of genomics institutions and laboratories in pathogen surveillance. In collaboration with Asia PGI, the PPP aims to broaden the scope of pathogen surveillance solutions available to partner countries. The program offers a differentiated and sustainable alternative, focusing on application-centric and workflow-driven solutions. For example, it supports the development of equitable, effective, relevant, and validated workflow solutions to address acute infectious diseases. "At the Duke-NUS Centre for Outbreak Preparedness, we believe that equitable access to pathogen genomic sequencing is fundamental to strengthening health security across South and Southeast Asia," said Paul Pronyk, Director of COP. "By collaborating with industry partners such as MGI, we are committed to ensuring that all communities in our region benefit from the latest advances in pathogen genomics – enabling early detection, informed response and ultimately, a healthier future for all." "We are proud to partner with Asia PGI to accelerate the application of cutting-edge sequencing technology in pathogen genomics," said Roy Tan, General Manager of MGI Asia Pacific. "Pathogen control is a pressing challenge for many countries in Asia. This partnership aims to improve the accessibility of pathogen genomics, empowering researchers and public health professionals in their fight against infectious diseases." In response to the growing demand for rapid and precise detection of infectious diseases, MGI has developed a diverse array of comprehensive products for various applications, including metagenomic sequencing, targeted sequencing, and whole genome sequencing of pathogenic microorganisms. Looking ahead, MGI is committed to continuing its innovation, providing automated, convenient, and efficient core tools for pathogen identification, drug resistance analysis, and traceability. For more information of PPP, please visit: About the Duke-NUS Centre for Outbreak Preparedness (COP) and its Asia Pathogen Genomic Initiative (Asia PGI) The Duke-NUS Centre for Outbreak Preparedness (COP) was established in 2022 to address the growing need for enhanced preparedness and response to infectious disease outbreaks in the Asian region. With a mission to bridge the gap between research, training, policy and practice, COP aims to enhance regional health security across South and Southeast Asia. The Asia Pathogen Genomic Initiative (Asia PGI) is a flagship initiative of COP, aiming to harness scientific and technical partnerships across Singapore and Asia to advance genomic sequencing for infectious disease elimination. For more information, please visit About Duke-NUS Medical School Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has spawned 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives. For more information, please visit About MGI MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. For more information, please visit the MGI website or connect with us on Twitter, LinkedIn or YouTube. View original content to download multimedia: SOURCE MGI Tech Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
09-06-2025
- Business
- Cision Canada
LogiSense Earns Elite "A" Rating from MGI Research
KITCHENER, ON, June 9, 2025 /CNW/ - LogiSense Corporation, a leader in agile usage-based billing and monetization solutions, today announced it has been recognized by MGI Research with an MGI 360™ Rating of 55 and a Positive Analyst Outlook, placing the company in the top quartile of global agile billing vendors. Among the 35 rated suppliers in the 2025 Agile Billing Top 50 Buyer's Guide, LogiSense is one of only five companies to receive this prestigious outlook — underscoring its excellence in product strength, financial stability, and customer satisfaction. "Being named to the top-rated tier by MGI Research is more than a score — it's a validation of our commitment to delivering value through agile, intelligent monetization," said Adam Howatson, CEO of LogiSense. "This recognition reinforces what our customers already experience: robust, scalable billing solutions purpose-built for growth." The report, published by MGI Research on May 1, 2025, highlights that success in agile billing isn't solely about being in the "top right corner" of the matrix — it's about finding the right fit. LogiSense stands out for its ability to support mid-to-large enterprises across digital, physical, and hybrid markets, especially those with moderate to high billing complexity and volume, including telecom, IoT, and SaaS organizations. The report also notes LogiSense's consistent profitability and high customer satisfaction as part of their selection as one of only 5 vendors given a positive outlook by the analyst firm. MGI cites LogiSense's usage mediation and rating capabilities as especially noteworthy — key for companies prioritizing dynamic pricing models and data-driven monetization strategies. About LogiSense LogiSense is a global provider of agile usage-based billing and monetization solutions, empowering B2B and B2C organizations to transform their revenue operations. Trusted by industry leaders such as Cisco, Garmin, Semtech, and Five9, LogiSense enables flexible pricing, streamlined billing, and scalable growth. Learn more at About MGI 360 Ratings: MGI 360 Ratings score is a uniform 0 to 100 supplier rating system comprised of over 150 unique data points. The scores condense hundreds of hours of research into simple, easy-to-understand ratings and recommendations to clearly demonstrate differences amongst software vendors. The overall score is comprised of five equally weighted major categories that account for up to 20 points in Product, Management, Channels, Strategy, and Finance. Learn more about MGI 360 Ratings.
